Biocon Limited Biocon Limited

Biocon Limited

BIOCON

Rank in Stocks #3390
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Share Price
$3.76
Market Cap
$5.14B
Change (1 day)
-2.11%
Change (1 year)
-7.08%
Country
IN
Trade Biocon Limited (BIOCON)

Category

Healthcare
P/S ratio for Biocon Limited (BIOCON)
P/S ratio as of October 2026 TTM: 2.80
According to Biocon Limited latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.80. At the end of 2024 the company had a P/S ratio of 2.19.
P/S ratio history for Biocon Limited from 2004 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 2.80 5.35%
2025 2.66 21.75%
2024 2.19 -0.79%
2023 2.20 -54.89%
2022 4.88 -28.13%
2021 6.80 33.65%
2020 5.08 -23.50%
2019 6.65 -22.37%
2018 8.56 49.90%
2017 5.71 101.52%
2016 2.83 -6.69%
2015 3.04 12.72%
2014 2.70 18.90%
2013 2.27 -0.79%
2012 2.28 -22.10%
2011 2.93 7.96%
2010 2.72 34.93%
2009 2.01 -59.64%
2008 4.99 -12.65%
2007 5.71 -7.76%
2006 6.19 3.79%
2005 5.97 -26.97%
2004 8.17 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.02 257.64%
US
40.55 1,347.05%
US
3.96 41.35%
AU
- -
CH
10.15 262.07%
NL